Lannett Company Inc's ability to collect accounts receivable sequentially worsen to 4.63, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Lannett Inc's Accounts Receivable average collection period in the Mar 31 2023 quarter, has increased to 79 days, from 78 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 172 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1724, from overall ranking in the second quarter 2023 at 3338.

What is Receivable Turnover Ratio?
What is Lannett Company Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

LCINQ Receivables Turnover Ratio	(Mar 31 2023) III. Quarter	(Dec 31 2022) II. Quarter	(Sep 30 2022) I. Quarter	(Jun 30 2022) IV. Quarter	(Mar 31 2022) III. Quarter
Y / Y Receivable Change	6.53 %	21.23 %	-41.77 %	-43.1 %	-44.22 %
Y / Y Revenue Change	1.41 %	-15.95 %	-27.23 %	-30.02 %	-30.27 %
Receivable Turnover Ratio (TTM)	4.63	4.68	5.19	4.85	4.61
LCINQ's Total Ranking	# 1724	# 3338	# 3327	# 1705	# 2830
Accounts Receivable average collection period days	79	78	70	75	79
Seq. Receivable Change	-15.17 %	46.3 %	-2.36 %	-12.09 %	-3.47 %
Seq. Revenue Change	9.29 %	-1.59 %	-0.41 %	-5.32 %	-9.42 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 39
Healthcare Sector	# 173
Overall Market	# 1724

Receivable Turnover Ratio Statistics
High	Average	Low
1.02	0.58	0.17
(Dec 31 2014)		(Jun 30 2020)

LCINQ Company Profile • Back to LCINQ Efficiency Comparisons • Compare LCINQ Receivables Turnover Ratio to its Competitors

Financial Statements
Lannett Inc's Accounts Receivable	$ 68 Millions	Visit LCINQ's Balance sheet
Lannett Inc's Sales TTM	$ 300 Millions	Visit LCINQ's Income Statement
Sources of LCINQ's Revenues		Visit LCINQ's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
LCINQ's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
LCINQ's Growth Rates	LCINQ's Roa	LCINQ's Inventory Turnover Ratio	LCINQ's Dividend Comparisons
LCINQ's Profitability Ratios	LCINQ's Roi	LCINQ's Asset Turnover Ratio	LCINQ's Dividend Growth
LCINQ's Valuation Ratios	LCINQ's Roe	LCINQ's Financial Strength Ratios	LCINQ's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Mymetics Corporation	12.09	$ 0.880 Millions	$ 0.073 Millions
Agenus Inc	11.88	$ 94.985 Millions	$ 7.994 Millions
Teladoc Health Inc	11.85	$ 2,470.734 Millions	$ 208.418 Millions
Immunogen inc	11.80	$ 120.573 Millions	$ 10.222 Millions
Biomerica Inc	11.79	$ 9.533 Millions	$ 0.809 Millions
Icu Medical Inc	11.67	$ 2,305.524 Millions	$ 197.537 Millions
Nektar Therapeutics	11.64	$ 88.827 Millions	$ 7.629 Millions
Harrow Inc	11.62	$ 92.578 Millions	$ 7.965 Millions
Integrated Biopharma Inc	11.45	$ 50.945 Millions	$ 4.448 Millions
Merus N v	11.32	$ 43.430 Millions	$ 3.836 Millions
Arcturus Therapeutics Holdings Inc	11.29	$ 281.040 Millions	$ 24.885 Millions
Sigilon Therapeutics Inc	10.88	$ 14.637 Millions	$ 1.345 Millions
Semler Scientific inc	10.85	$ 60.876 Millions	$ 5.611 Millions
Option Care Health Inc	10.79	$ 4,044.799 Millions	$ 374.928 Millions
Intercept Pharmaceuticals inc	10.78	$ 294.522 Millions	$ 27.323 Millions
National Healthcare Corp	10.70	$ 1,076.318 Millions	$ 100.635 Millions
Mirati Therapeutics Inc	10.66	$ 18.894 Millions	$ 1.773 Millions
Hcw Biologics Inc	10.62	$ 3.646 Millions	$ 0.343 Millions
Nrc Health	10.47	$ 149.600 Millions	$ 14.293 Millions
United Therapeutics Corporation	10.43	$ 1,981.300 Millions	$ 190.000 Millions
Utah Medical Products Inc	10.33	$ 52.478 Millions	$ 5.082 Millions
Sunlink Health Systems Inc	10.32	$ 46.918 Millions	$ 4.545 Millions
Novavax inc	10.27	$ 1,358.852 Millions	$ 132.268 Millions
Atrion Corporation	10.17	$ 176.361 Millions	$ 17.339 Millions
Ultragenyx Pharmaceutical Inc	10.12	$ 383.890 Millions	$ 37.952 Millions
Protalix Biotherapeutics inc	9.94	$ 41.141 Millions	$ 4.141 Millions
Poseida Therapeutics Inc	9.92	$ 139.400 Millions	$ 14.056 Millions
American Bio Medica Corporation	9.91	$ 0.726 Millions	$ 0.073 Millions
Milestone Scientific Inc	9.88	$ 8.703 Millions	$ 0.881 Millions
Sunshine Biopharma Inc	9.85	$ 9.117 Millions	$ 0.926 Millions

Date modified: 2026-09-08T15:10:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.